HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of necrobiosis lipoidica with etanercept and adalimumab.

AuthorsKevin S Zhang, Long T Quan, Sylvia Hsu
JournalDermatology online journal (Dermatol Online J) Vol. 15 Issue 12 Pg. 12 (Dec 15 2009) ISSN: 1087-2108 [Electronic] United States
PMID20040262 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Adalimumab
  • Etanercept
Topics
  • Adalimumab
  • Adult
  • Anti-Inflammatory Agents (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G (therapeutic use)
  • Necrobiosis Lipoidica (drug therapy)
  • Receptors, Tumor Necrosis Factor (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: